Pubertal Changes in Biochemical Markers of Growth

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Hormone Research in Paediatrics

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000071225PMID 12955017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone metabolism markers and bone mass in healthy pubertal boys and girls

  2002cited by this paper
• Leptin Acts as a Growth Factor on the Chondrocytes of Skeletal Growth Centers

  2002cited by this paper
• Role of leptin in bone growth: central player or peripheral supporter?

  2002cited by this paper
• Leptin receptor isoform expression in rat osteoblasts and their functional analysis

  2002cited by this paper
• Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study.

  2002cited by this paper
• Leptin Inhibits Osteoclast Generation

  2002cited by this paper
• A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency.

  2001cited by this paper
• Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men.

  2001cited by this paper
• Growth hormone and sex steroids. Interactions in puberty.

  2001cited by this paper
• Biochemical Measurements of Bone Turnover in Children and Adolescents

  2000cited by this paper
• Leptin is a potent stimulator of bone growth in ob/ob mice.

  2000cited by this paper
• Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

  2000cited by this paper
• The relationship between leptin concentration and bone metabolism in the human fetus.

  2000cited by this paper
• Dynamics of bone turnover in children with GH deficiency treated with GH until final height.

  2000cited by this paper
• Serum leptin concentration, body composition, and gonadal hormones during puberty

  1999cited by this paper
• Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.

  1999cited by this paper
• Growth Hormone Treatment Downregulates Serum Leptin Levels in Children Independent of Changes in Body Mass Index

  1999cited by this paper
• Clinical utility of markers of bone turnover in children and adolescents.

  1998cited by this paper
• Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment.

  1998cited by this paper
• Collagen formation and degradation increase during growth hormone therapy in children.

  1997cited by this paper
• Collagen metabolites in the prediction of response to GH therapy in short children.

  1997cited by this paper
• Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.

  1997cited by this paper
• Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

  1997cited by this paper
• Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.

  1997cited by this paper
• Quantification of Biochemical Markers of Bone Turnover by Kinetic Measures of Bone Formation and Resorption in Young Healthy Females

  1997cited by this paper
• Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.

  1997cited by this paper
• Urinary Pyridinoline and Deoxypyridinoline in Healthy Children and in Children with Growth Hormone Deficiency

  1996cited by this paper
• Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.

  1996cited by this paper
• Molecular basis and clinical application of biological markers of bone turnover.

  1996cited by this paper
• The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.

  1996cited by this paper
• Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.

  1995cited by this paper
• Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.

  1995cited by this paper
• Weight-reducing effects of the plasma protein encoded by the obese gene.

  1995cited by this paper
• Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.

  1995cited by this paper
• Twenty-four-Hour Osteocalcin, Carboxyterminal Propeptide of Type I Procollagen, and Aminoterminal Propeptide of Type III Procollagen Rhythms in Normal and Growth-Retarded Children

  1994cited by this paper
• Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.

  1993cited by this paper
• Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.

  1992cited by this paper
• Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1 st year of life to adulthood and in metabolic bone diseases

  1992cited by this paper
• Serum Concentrations of the Type I and III Procollagen Propeptides as Biochemical Markers of Growth Velocity in Healthy Infants and Children and in Children with Growth Disorders

  1991cited by this paper
• Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency.

  1991cited by this paper
• Serum Osteocalcin Levels in Patients with GH Deficiency before and during GH Treatment

  1991cited by this paper
• Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.

  1990cited by this paper
• Serum bone GLA‐protein in growth hormone deficient children

  1986cited by this paper
• Radioimmunoassay for Type I Procollagen in Growth Hormone-deficient Children before and during Treatment with Growth Hormone

  1985cited by this paper

• Assessment of Biochemical Bone Turnover Markers in Polish Healthy Children and Adolescents

  2024cites this paper
• Impact of high fat and low lean mass phenotype on bone mineral content: A cross-sectional study of Chinese adolescent population.

  2024cites this paper
• Impact of skeletal maturation on bone metabolism biomarkers and bone mineral density in healthy Brazilian male adolescents.

  2023cites this paper
• Die Knochenmarker BSP, CTX und NTX und deren Publikationscharakteristika im Rahmen einer bibliometrischen Analyse

  2021cites this paper
• Übersichten : Arbeitsmedizin

  2021cites this paper
• Norms for Clinical Use of CXM, a Real-Time Marker of Height Velocity

  2020cites this paper
• Serum Osteocalcin Levels in Girls with Central Precocious Puberty: Relation to the Onset of Puberty.

  2018cites this paper
• Association Between Vitamin D and Carboxy-Terminal Cross-Linked Telopeptide of Type I Collagen in Children During Growth Hormone Replacement Therapy.

  2018cites this paper
• Clinical Reasoning: A case of subacute cognitive decline in a 76-year-old man

  2016cites this paper
• Pseudotumoral presentation of cerebral amyloid angiopathy–related inflammation

  2016cites this paper
• eference curves of the body fat index in adolescents nd their association with anthropometric variables enata

  2015cites this paper
• Reference curves of the body fat index in adolescents and their association with anthropometric variables.

  2015cites this paper
• Marqueurs biochimiques de la formation et de la résorption osseuse

  2015cites this paper
• Artigo OriginalReference curves of the body fat index in adolescents and their association with anthropometric variablesCurvas de referência do índice de adiposidade corporal de adolescentes e sua relação com variáveis antropométricas

  2015cites this paper
• MER5101, a Novel Aβ1-15:DT Conjugate Vaccine, Generates a Robust Anti-Aβ Antibody Response and Attenuates Aβ Pathology and Cognitive Deficits in APPswe/PS1ΔE9 Transgenic Mice

  2013cites this paper
• Body fat percentiles of Brazilian adolescents according to age and sexual maturation: a cross-sectional study

  2013cites this paper
• The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls

  2013cites this paper
• TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice.

  2013cites this paper
• Aβ-related angiitis

  2013cites this paper
• Leptin’s effect on accelerated fracture healing after traumatic brain injury

  2013cites this paper
• IFN-γ Production by Amyloid β–Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer’s Disease

  2013cites this paper
• Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions

  2012cites this paper
• Immunotherapy for Alzheimer's disease.

  2012cites this paper
• An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ

  2012cites this paper
• Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific

  2012cites this paper
• Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission

  2012cites this paper
• Bone metabolism biomarkers, body weight, and bone age in healthy Brazilian male adolescents

  2012cites this paper
• Amino‐terminal propeptide of C‐type natriuretic peptide (NTproCNP) predicts height velocity in healthy children

  2012cites this paper
• Perception of Adolescents Towards Health Related Issues in Secondary Schools, Kuwait

  2012influential citation
• Biochemical bone turnover markers in children and adolescents

  2012cites this paper
• Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration

  2011cites this paper
• Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases*

  2011cites this paper
• South Wales Joint Neuroscience Meeting, Bridgend, 29 April 2010: a 66-year-old man who suddenly couldn't drive

  2011cites this paper
• Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-β Immunotherapy

  2011cites this paper
• Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: A case report

  2011cites this paper
• The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects

  2011cites this paper
• Impacto da maturação esquelética em biomarcadores do metabolismo ósseo e na densidade mineral óssea em adolescentes brasileiros saudáveis

  2011cites this paper
• Effect of public deliberation on attitudes toward surrogate consent for dementia research

  2011cites this paper
• Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?

  2011cites this paper
• Cerebral amyloid angiopathy related inflammation: three case reports and a review

  2010cites this paper
• Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.

  2010cites this paper
• Active Immunization with Amyloid-β 1–42 Impairs Memory Performance through TLR2/4-Dependent Activation of the Innate Immune System

  2010cites this paper
• Role of various cytokines and growth factors in pubertal development.

  2010cites this paper
• The Long-Term Effects of Prematurity and Intrauterine Growth Restriction on Cardiovascular, Renal, and Metabolic Function

  2010cites this paper
• Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity

  2009cites this paper
• A marker of growth differs between adolescents with high vs. low sugar preference.

  2009cites this paper
• HLA-DR Alleles in Amyloid β-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele1

  2009cites this paper
• Adoptive Transfer of T Lymphocytes Sensitized against the Prion Protein Attenuates Prion Invasion in Scrapie-Infected Mice1

  2009cites this paper
• Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography-mass spectrometry.

  2009cites this paper
• APOE ε4 and bapineuzumab

  2009cites this paper
• Amyloid Reduction by Amyloid-β Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease

  2009cites this paper
• A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

  2009cites this paper
• Surrogate consent for dementia research

  2009cites this paper
• Cytokine-Mediated Inhibition of Fibrillar Amyloid-β Peptide Degradation by Human Mononuclear Phagocytes1

  2008cites this paper
• A Two-Year Study with Fibrillar β-Amyloid (Aβ) Immunization in Aged Canines: Effects on Cognitive Function and Brain Aβ

  2008cites this paper
• Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies.

  2008cites this paper
• Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.

  2008cites this paper
• Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.

  2008cites this paper
• Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

  2008cites this paper
• Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.

  2007cites this paper
• Polylactide-Coglycolide Microspheres CoEncapsulating Recombinant Tandem Prion Protein with CpG-Oligonucleotide Break Self-Tolerance to Prion Protein in Wild-Type Mice and Induce CD4 and CD8 T Cell Responses1

  2007cites this paper
• Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble/Oligomeric Aβ Species in Amyloid Precursor Protein Transgenic Mice

  2007cites this paper
• Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography

  2007cites this paper
• Course of cerebral amyloid angiopathy–related inflammation

  2007cites this paper
• Conformation-sensitive Antibodies against Alzheimer Amyloid-β by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide*

  2007cites this paper
• Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced β-Cell Apoptosis in h-IAPP Transgenic Mice

  2007cites this paper
• Antibody-Mediated Clearance of Amyloid-β Peptide from Cerebral Amyloid Angiopathy Revealed by Quantitative In Vivo Imaging

  2007cites this paper
• Maturity indicators in spinal deformity.

  2007cites this paper
• Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children

  2007cites this paper
• A 63-year-old man with headaches and behavioral deterioration

  2007cites this paper
• Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhage

  2007cites this paper
• Active β-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of β-Amyloid

  2007cites this paper
• Investigations on bone metabolism in intact and ovariohysterectomised

  2007cites this paper
• Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

  2007cites this paper
• Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.

  2007cites this paper
• Subcutaneous Nogo Receptor Removes Brain Amyloid-β and Improves Spatial Memory in Alzheimer's Transgenic Mice

  2006cites this paper
• Volunteering for early phase gene transfer research in Parkinson disease

  2006cites this paper
• Therapeutic approaches to Alzheimer's disease.

  2006cites this paper
• Increased T Cell Recruitment to the CNS after Amyloid β1–42 Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1

  2006cites this paper
• Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice

  2006cites this paper
• Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease

  2006cites this paper
• Immunotherapeutic relief from persistent infections and amyloid disorders

  2006cites this paper
• Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice

  2006cites this paper
• Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

  2006cites this paper
• Birth weight, puberty, and systolic blood pressure in children and adolescents: a longitudinal analysis

  2006cites this paper
• Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.

  2006cites this paper
• The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment

  2005cites this paper
• Prototype Alzheimer’s Disease Vaccine Using the Immunodominant B Cell Epitope from β-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide1

  2005cites this paper
• What do people at risk for Alzheimer disease think about surrogate consent for research?

  2005cites this paper
• IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor

  2005cites this paper
• Invasion of Hematopoietic Cells into the Brain of Amyloid Precursor Protein Transgenic Mice

  2005cites this paper
• Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.

  2005cites this paper
• Immunization therapy for Alzheimer disease?

  2005cites this paper
• Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

  2005cites this paper
• Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD

  2005cites this paper
• Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy

  2005cites this paper
• Protection against Osteoporosis by Active Immunization with TRANCE/RANKL Displayed on Virus-Like Particles

  2005cites this paper
• Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines

  2005cites this paper
• Valproat und Knochenstoffwechsel

  2005cites this paper
• Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease

  2005cites this paper